Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.
about
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected diseaseDevelopments in Diagnosis of Visceral Leishmaniasis in the Elimination EraSystematic review of biomarkers to monitor therapeutic response in leishmaniasisDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral LeishmaniasisThe performance of serological tests for Leishmania infantum infection screening in dogs depends on the prevalence of the diseaseIdentification and Characterization of a Novel, 37-Kilodalton Leishmania donovani antigen for diagnosis of Indian visceral leishmaniasis.Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysisDevelopments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic testPolymorphism in the HASPB repeat region of East African Leishmania donovani strainsComparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphismsComparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients.rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in SudanSignificantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India.The development and clinical evaluation of second-generation leishmaniasis vaccines.Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.Local Production of a Liquid Direct Agglutination Test as a Sustainable Measure for Control of Visceral Leishmaniasis in SudanEvaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasisApplication of Recombinant Proteins for Serodiagnosis of Visceral Leishmaniasis in Humans and Dogs.Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.Leishmaniasis: new insights from an old and neglected disease.Recent advances in clinical parasitology diagnostics.Leishmania vaccine development: exploiting the host-vector-parasite interface.Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures.Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan.Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined AntigensVisceral leishmaniasis: a forgotten epidemic.Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin America.Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.Recombinant K28 antigen in ELISA in the diagnosis of canine visceral leishmaniosis.Cloning of K26 Hydrophilic Antigen from Iranian Strain of Leishmania infantum.Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.Global Burden of Skin Disease: Inequities and Innovations.Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial.Prevalence of and Factors Associated with Negative Microscopic Diagnosis of Cutaneous Leishmaniasis in Rural Peru
P2860
Q24193697-6B54FEEF-94BC-4FCD-8A3C-E6C33932D9F6Q26769062-8C322C99-32DD-49ED-8D64-901DA76BC620Q26866450-9D26A22C-B697-4531-A02F-6C49C41053DAQ30275257-A30793C1-84B3-44F3-8193-F930C644CD8AQ33554455-4250B5AF-03EF-42AB-9E46-384A92E77635Q33765068-56B01BC6-03EC-4622-92C3-C7727F3C72ACQ33848772-4DB4BCFB-7D9A-4B8F-8BE2-58232D7F55CBQ34150116-11C5DD7F-173E-4543-ACAD-AC9267E395E1Q34328882-76F12006-EDCD-480E-BD5A-96F48AA12523Q34395015-043405F1-BF40-4270-BD87-235F535F44FCQ34566085-F3F29B8B-E987-44A4-A458-FCF1FA11D962Q34613574-51CF2131-BAE8-4C33-A2A8-A00C8544EDF3Q34640110-B0DE8ACB-A0A5-4E6B-8BD4-C260E3D64709Q34855381-2C958DB8-6C04-4885-9227-DF5539DD70B6Q35109189-122F5DBC-92F8-4F16-900D-38274D9AEE49Q35143788-21CCB705-A1CA-49C0-8178-F3FE7D67E6F6Q35293139-29AB6E7A-7977-4121-A6E2-FC92827D5BEDQ35986733-9224449D-13E1-4088-B4F8-85CCAF1675F9Q36163680-68D27C04-EECA-4703-A7D8-DA2E92173771Q36869648-F21162DA-F018-4C9E-82AD-C9EA7F4E3105Q37064488-257BB034-6EF1-4B21-BD97-0C5A809E848EQ37106269-D9DB8A61-A4A8-4F41-AA91-EED327AAA15FQ37639367-8490A474-D880-4C2E-B1A3-2865DC75A7BCQ37687083-FBBC8F36-7514-406C-B5EF-430F9C482BD2Q37870821-7BF09C63-3984-4E16-AF58-B6A8BD537FFCQ38250441-72FC61AF-0267-4BA9-8B32-961BDB2D6087Q38643410-7AE8D6A0-6494-44BD-8352-AC4CD8103AB6Q38730656-1C66E93B-CBD0-4F9C-83F6-081B7F66A3A7Q39279549-485CBF74-2EA3-435C-AB98-FACD942DACC8Q39577607-40069788-A2FF-4957-B953-183750DDBB8EQ39632056-3ACC57CF-8D5F-4C9D-B00A-A60ED7CFC327Q40475078-41F26CBF-0242-4507-BFF2-7AFC7196B132Q40681016-550F0B66-0C7C-48C4-A90E-D4A19E04687DQ41656767-78C563C9-62FC-4A4C-A0C9-BEC7C7E80C51Q43177120-70D5A375-3260-4208-AF84-4F3207E5F1B5Q47199661-9278E31B-B762-4162-A8B7-64DE16AF9916Q48259367-20B9362A-39A4-44A1-955E-E498BC296BECQ48539392-5D6967A5-73AA-436C-98D8-5217D7D19B0FQ53080229-94A8BB17-9A79-47C5-B531-F75E94FEF335Q57171414-8F042A58-94BB-411A-AC37-A956BD2593C6
P2860
Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Design, development and evalua ...... sis of visceral leishmaniasis.
@ast
Design, development and evalua ...... sis of visceral leishmaniasis.
@en
type
label
Design, development and evalua ...... sis of visceral leishmaniasis.
@ast
Design, development and evalua ...... sis of visceral leishmaniasis.
@en
prefLabel
Design, development and evalua ...... sis of visceral leishmaniasis.
@ast
Design, development and evalua ...... sis of visceral leishmaniasis.
@en
P2093
P2860
P1476
Design, development and evalua ...... sis of visceral leishmaniasis.
@en
P2093
Ajay Bhatia
Asem O Abdoon
Danny Colombara
Garner G Moulton
Jacqueline Whittle
Javan Esfandiari
Jeffrey A Guderian
Maowia M Mukhtar
Peter Chun
Raodoh Mohamath
P2860
P304
P356
10.1371/JOURNAL.PNTD.0000822
P407
P5008
P577
2010-09-14T00:00:00Z